Preventing and responding to dependence on prescribed and over-the-counter medicines: national policy, local action
|
|
|
- Hester Blake
- 8 years ago
- Views:
Transcription
1 Preventing and responding to dependence on prescribed and over-the-counter medicines: national policy, local action Steve Taylor, Programme Manager Alcohol, Drugs & Tobacco Division - Health & Wellbeing Directorate 15 May 2014
2 Brief recent history All Party Group launches inquiry into the misuse of prescription-only and over-thecounter medicines All Party Group publishes inquiry, concerns at: Availability by prescription and sale (POM/OTC medicines) Possible mis-prescribing of tranquillisers by GPs Possible shortage of services to help people addicted to medicines 2 Addiction to medicines policy May 2014
3 Brief recent history (continued) DH commissioned two reports: Literature review published evidence on the extent of the problem and how best to respond to dependence (National Addictions Centre) Consultative review Investigate prescribing patterns and the services and support available to people who develop problems. 2011: NTA and NAC reports published Roundtable convened 2013: PHE responsible for programme delivery Products/activities: consensus, conference, commissioning guide, practice examples, pilots 3 Addiction to medicines policy May 2014
4 Service delivery Access Surveillance NTA report findings 1. Over the last 19 years dispensing of benzodiazepines has decreased but there has been an increase in the prescribing of anxiolytic benzodiazepines and the sale and prescription of opioid painkillers 2. Long-term prescribing increases the likelihood of dependency but this is not inevitable 3. There are sub national and local variations in the level of prescribing 4. Local areas have access to the information needed to address any issues. 1. Most local areas offer treatment for people who develop problems in relation to medicines, but some provide very little 2. Those who do not have concurrent problems with illegal drug use are a distinct population within drug treatment services but may be under representative of the treatment need 3. There is sub national variation in the level of treatment reported 4. Trends in treatment presentation suggest that there could be an increase in need within this group, in relation to opioid painkillers 1. Local areas report commissioning of services that are flexible, in order to meet local need 2. Services report providing a wide range of interventions in a variety of settings 3. Performance data suggests that these services are meeting the needs of those reporting a problem with just POM/OTC 4. Services and local areas report that there is room for improving understanding and service delivery for addiction to medicine. 4 Addiction to medicines policy May 2014
5 Range of populations People who entirely inadvertently became dependent on prescribed medicines Damaged people who were always liable to become dependent on something as a way of coping with their problems People who self-medicate but get into problems People who start on prescription or OTC drugs because they re available/legal People who prefer illicit drugs but will top-up/substitute with medicines when they have to 5 Addiction to medicines policy May 2014
6 Benzodiazepine (and z-drug) px 6 Addiction to medicines policy May 2014
7 Regional variation 7 Addiction to medicines policy May 2014
8 Opioid pain medicines px Trends in the prescribing of opiates analgesics in general practice in England (National Treatment Agency May 2011) 8 Addiction to medicines policy May 2014
9 Number of patients (10 4 ) Mostly for non-cancer Prescriptions- noncancer Prescriptions- cancer Patients- noncancer Patients- cancer Number of prescriptions ( 10 4 ) Total number of prescriptions and number of patients stratified by non-cancer and cancer CPRD (England) Addiction to medicines policy May 2014
10 Px opioid deaths mirror prescribing may signal an emerging problem in the UK similar to the issue that is now well established in the USA. Prescription opioid abuse in the UK, Giraudon I et al., British Journal of Clinical Pharmacology Addiction to medicines policy May 2014
11 Again, tremendous regional variation Variation between Strategic Health Authorities in prescribing of opioid analgesics (Quarter to March 2010) NHS prescribing services. 11 Addiction to medicines policy May 2014
12 Interesting but... Trend data tells us something about the use of these medicines Levels of prescribing can identify areas where there might need to be further focus (particularly at a practice level) But... Higher levels of prescribing do not necessarily mean that these medicines are not being used appropriately 12 Addiction to medicines policy May 2014
13 It s not just benzos and OPM Pregabalin and gabapentin Antidepressants Over-the-counter medicines 13 Addiction to medicines update February 2014
14 Pain in secure environments Concentration of risk factors for chronic pain and depression/anxiety Difficulty distinguishing genuine patients Opportunities for regular assessment Non-pharmacological interventions Bridges 14 Addiction to medicines policy May 2014
15 What do we do? 15 Addiction to medicines policy May 2014
16 Service delivery Access Surveillance NTA report questions 1. How can we be better informed about the overall extent of the issue and what drives changes over time? 2. What information do local areas require to support them to better understanding need 3. What should be done to improve public understanding of treatments for anxiety, insomnia and pain? 4. What actions should be taken to prevent problems in relation to addiction to medicines from occurring in the first place? 1. How can we ensure that the availability of support reflects the local need and changes over time? 2. How can we make people more aware of the availability of services? 1. What training or guidance is needed to support clinicians and how can this best impact on their practice? 2. How should we measure the outcomes of treatment for this group? 3. How can we improve the coordination of care for patients across all health services (i.e. GP services, Talking therapies, mental health and pain services.) 16 Addiction to medicines policy May 2014
17 Assessing need Data NHS Px Services NDTMS (quarterly reports, JSNA) but dependence and tx services only Intelligence Medicines management Professionals: pharmacists, doctors, etc Patients/service users Audit 17 Addiction to medicines policy May 2014
18 Service responses Primary care Specialists: Support to GPs Specialist treatment Dedicated or integrated Other non-drug specialist responses: Access to psychological therapies Links to mental health and pain services 18 Addiction to medicines policy May 2014
19 What did NTA (and partners) do? Round table Consensus statement Conference NDTMS/JSNA Core medical competencies IAPT eligibility MHRA oversight MHRA e-learning CDAOs 19 Addiction to medicines policy May 2014
20 What is PHE (and partners) doing? Four areas in consensus: Support to GPs and other healthcare professionals Improve access to treatment and support Media and political Refresh JSNA data/guidance RCGP/CPPE e-learning SMMGP face-to-face training Improve the commissioning of services Highlight best practice to improve public and professional awareness RCGP factsheets Commissioners guide Secure environments guidance Practice examples OPM core resource BMA review 20 Addiction to medicines policy May 2014
21 Resources 21 Addiction to medicines update February 2014
22 How important? It s real Drug strategy s wider remit Public health Secure environments Future But keep it in proportion 22 Addiction to medicines policy May 2014
23 Summary of the policy position ATM is a multi-faceted and complex issue that government takes seriously From the centre we provide data and advice to support local areas to understand and respond to their local ATM problems Working with many stakeholders we have a wide-ranging programme of activity Like many other social and health issues, the problems and their solutions need to be owned jointly by the local authority, NHS England, CCGs and patients (likely through health and wellbeing boards) It is for them (you) to determine the most-effective shape of local responses and where they come from, not for us to dictate 23 Addiction to medicines policy May 2014
addiction to medicine
An investigation into the configuration and commissioning of treatment services to support those who develop problems with prescriptiononly or over-the-counter medicine addiction to medicine www.nta.nhs.uk
Alcohol and drugs JSNA support pack
Alcohol and drugs JSNA support pack Key data to support planning for effective drugs prevention, and recovery MILTON KEYNES MILTON KEYNES J8B SUPPORTING INFORMATION This pack provides key performance and
Drugs and Alcohol in Primary Care Steve Brinksman Clinical Lead SMMGP
Drugs and Alcohol in Primary Care Steve Brinksman Clinical Lead SMMGP Habit is habit, and not to be flung out of the window by any man, but coaxed down-stairs one step at a time. Samuel Langhorne Clemens
Support to Primary Care from Derbyshire Substance Misuse Service for prescribed / OTC drug dependence
Support to Primary Care from Derbyshire Substance Misuse Service for prescribed / OTC drug dependence SUMMARY 1) Derbyshire Substance misuse service provides Psycho-social treatment interventions for ALL
THE DATA FOR ADULT DRUG TREATMENT LINCOLNSHIRE LINCOLNSHIRE E08B 32
THE DATA FOR ADULT DRUG TREATMENT LINCOLNSHIRE LINCOLNSHIRE E08B 32 THIS SUPPORTING INFORMATION This pack sets out the investment in drug in your area. It also gives key performance information about your
Statistics on individuals in drug or alcohol treatment in receipt of working-age benefits. Figures for 2011/12, England
Statistics on individuals in drug or alcohol treatment in receipt of working-age benefits Figures for 2011/12, England 31 st July 2015 Contents Overview... 3 Results Summary... 3 Methodology... 4 Data
Sample Patient Agreement Forms
Sample Patient Agreement Forms Introduction This resource includes two sample patient agreement forms that can be used with patients who are beginning long-term treatment with opioid analgesics or other
7.11 Substance misuse
7.11 Substance misuse Substance misuse is defined by NICE as intoxication by or regular excessive consumption of and/or dependence on psychoactive substances, leading to social, psychological, physical
Exercise therapy and the treatment of mild or moderate depression in primary care
Exercise therapy and the treatment of mild or moderate depression in primary care Up and running? Executive summary Why isn t exercise referral offered by GPs? According to our research, only 42% of GPs
POWDER COCAINE: HOW THE TREATMENT SYSTEM IS RESPONDING TO A GROWING PROBLEM
Effective treatment is available for people who have a powder-cocaine problem seven in ten of those who come into treatment either stop using or reduce their use substantially within six months POWDER
Addressing Alcohol and Drugs in the Community. Cabinet member: Cllr Keith Humphries - Public Health and Protection Services
Wiltshire Council Cabinet 17 April 2012 Subject: Addressing Alcohol and Drugs in the Community Cabinet member: Cllr Keith Humphries - Public Health and Protection Services Key Decision: Yes Executive Summary
UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths
UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths Joanna G Katzman, M.D., M.S.P.H Director, UNM Pain Center Associate Professor,
National Poll: Chronic Pain and Drug Addiction
National Poll: Chronic Pain and Drug Addiction April 2013 Results of a New Public Opinion Poll National Poll on Chronic Pain and Drug Addiction The National Poll on Chronic Pain was conducted online in
Drug misuse and dependence: UK guidelines on clinical management
Drug misuse and dependence: UK guidelines on clinical management Response by Cornwall Council Date 2014 Service responding: Drug and Alcohol Action Team (DAAT) Directorate: Education, Health and Social
Capital Challenge. Tackling Hepatitis C in London
Capital Challenge Tackling Hepatitis C in London Contents Foreword 3 The current state of hepatitis C in London 4-5 Delivering improved hepatitis C outcomes in London 8-11 What next in London? 12 References
Alcohol and drugs prevention, treatment and recovery: why invest?
Alcohol and drugs prevention, treatment and recovery: why invest? 1 Alcohol problems are widespread 9 million adults drink at levels that increase the risk of harm to their health 1.6 million adults show
Governor s Task Force on Mental Health and Substance Use. www.ncdhhs.gov/mhsu
Governor s Task Force on Mental Health and Substance Use www.ncdhhs.gov/mhsu Problem Statement 97 Painkiller prescriptions per 100 North Carolinians Number of deaths by drug overdose in North Carolina
ADVISORY OPINION THE USE OF CONTROLLED SUBSTANCES FOR THE TREATMENT OF CHRONIC PAIN
Janice K. Brewer Governor Arizona State Board of Nursing 4747 North 7 th Street, Suite 200 Phoenix, AZ 85014-3655 Phone (602) 889-5150 Fax - (602) 889-5155 E-Mail: arizona@azbn.gov Home Page: http://www.azbn.gov
Parallel Session 2.2: Health Promoting Pharmacotherapy in the Triangle Patient/General Practicioner/Community Pharmacist
Parallel Session 2.2: Health Promoting Pharmacotherapy in the Triangle Patient/General Practicioner/Community Pharmacist The Methadone Treatment Protocol in Ireland Ailís ní Riain, Irish College of General
Opioid Agreement for Center for Pain Management S.C.
Opioid Agreement for Center for Pain Management S.C. Patient Name: DOB: I am the patient named above. I have agreed to use pain medication as part of my treatment for chronic pain. I understand that these
What you should know about treating your pain with opioids. Important information on the safe use of opioid pain medicine.
What you should know about treating your pain with opioids Important information on the safe use of opioid pain medicine. If your healthcare provider has determined that opioid therapy is right for you,
Costing report. Drug misuse: psychosocial interventions and opioid detoxification. Implementing NICE guidance. July 2007
Drug misuse: psychosocial interventions and opioid detoxification Costing report Implementing NICE guidance July 2007 NICE clinical guidelines 51 and 52 National costing report: Drug misuse guidelines
Sheffield Future Commissioning of Drug & Alcohol Community Treatment
Sheffield Future Commissioning of Drug & Alcohol Community Treatment Magdalena Boo, Joint Commissioning Manager Scope of the Plan IN SCOPE Adults 18+ (young people s services are separately commissioned)
Injectable heroin (and injectable methadone) Potential roles in drug treatment
Injectable heroin (and injectable methadone) Potential roles in drug treatment Full guidance report May 2003 National Treatment Agency More treatment, better treatment, fairer treatment The National Treatment
Clinical Priorities for Alcohol and Drugs in Public Health
Clinical Priorities for Alcohol and Drugs in Public Health What do we need to Measure up to? Dr Michael Kelleher Clinical Lead Alcohol and Drugs Team, Health and Wellbeing Directorate SMMGP 8 th Primary
How you can protect investments, reduce health inequalities and save lives in your borough
Reducing health inequalities in London by addressing hepatitis C Briefing for councillors: Reducing health inequalities in London by addressing hepatitis C How you can protect investments, reduce health
SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY COUNCIL OF GOVERNORS 2 ND DECEMBER 2014
SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST C EXECUTIVE SUMMARY COUNCIL OF GOVERNORS 2 ND DECEMBER 2014 Subject: Supporting Director: Author: Status 1 NHS England Five Year Forward View A Summary
02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION
Effective June 13, 2010 02-313, 02-373, 02-380, 02-383, 02-396 Chapter 21 page 1 02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION 313 BOARD OF DENTAL EXAMINERS 373 BOARD OF LICENSURE IN MEDICINE
Improving smoking cessation in drug and alcohol treatment
Improving smoking cessation in drug and alcohol treatment Interim briefing on Turning Point s PHE-supported smoking cessation pilots Tobacco smoking is prevalent among drug and alcohol users, and contributes
Guidelines for the Prescribing, Supply and Administration of Methadone and Buprenorphine on Transfer of Care
Hull & East Riding Prescribing Committee Guidelines for the Prescribing, Supply and Administration of Methadone and Buprenorphine on Transfer of Care 1. BACKGROUND Patients who are physically dependent
Managing Chronic Pain in Adults with Substance Use Disorders
Question from chapter 1 Managing Chronic Pain in Adults with Substance Use Disorders 1) What is the percent of chronic pain patients who may have addictive disorders? a) 12% b) 22% c) 32% d) 42% 2) Which
BUILDING RECOVERY IN COMMUNITIES www.nta.nhs.uk
For the small percentage of under- 18s who get into difficulties with drugs or alcohol, the problems can become significant SUBSTANCE MISUSE AMONG YOUNG PEOPLE 2011-12 BUILDING RECOVERY IN COMMUNITIES
2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov
OHIO AUTOMATED RX REPORTING SYSTEM 2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov OHIO AUTOMATED RX REPORTING SYSTEM What is OARRS? To address the growing misuse and diversion
Alcohol and drugs. Introduction. The legal position
Alcohol and drugs Introduction There are no reliable figures for the misuse of drugs and alcohol by NHS staff but a survey in 2001 by Alcohol Concern and Drugscope suggested that 60 per cent of employers
The story of drug treatment
EFFECTIVE TREATMENT CHANGING LIVES www.nta.nhs.uk www.nta.nhs.uk 1 The story of drug treatment The use of illicit drugs is declining in England; more and more people who need help with drug dependency
1. Residential Rehabilitation Services in Brighton and Hove
24 Although a formal committee of the city council, the Health & Wellbeing Board has a remit which includes matters relating to the Clinical Commissioning Group (CCG), the Local Safeguarding Board for
Benzodiazepine Detoxification and Reduction of Long term Use
Benzodiazepine Detoxification and Reduction of Long term Use Malcolm Lader 1 Model of general drug misuse and dependence. Tactical interventional options Social dimension Increasing breaking of social
DMRI Drug Misuse Research Initiative
DMRI Drug Misuse Research Initiative Executive Summary Dexamphetamine Substitution as a Treatment of Amphetamine Dependence: a Two-Centre Randomised Controlled Trial Final Report submitted to the Department
NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SPECIAL HEALTH AUTHORITY TENTH WAVE WORK PROGRAMME DRUG MISUSE. Psychosocial interventions in drug misuse
Attachment B NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SPECIAL HEALTH AUTHORITY TENTH WAVE WORK PROGRAMME DRUG MISUSE Psychosocial interventions in drug misuse On 16 th June 2004 the Department of Health
Policy for the issue of permits to prescribe Schedule 8 poisons
Policy for the issue of permits to prescribe Schedule 8 poisons May 2011 Introduction The Victorian Drugs, Poisons and Controlled Substances (DPCS) legislation sets out certain circumstances when a medical
Primary care drug and alcohol treatment: commissioning and provision against a backdrop of localism
Primary care drug and alcohol treatment: commissioning and provision against a backdrop of localism This joint paper considers the future impact of the changing commissioning environment on primary care
Extended brief interventions: up to 12 sessions of one to one support and access to group work
Annex 1: Services provided by Kingston Wellbeing Service Alcohol and drug treatment services The service provides three care pathway options: Brief Interventions: 1-3 sessions of one to one support Extended
Part 1: Opioids and Overdose in the U.S. and New Mexico. Training: New Mexico Pharmacist Prescriptive Authority for Naloxone Protocol 7/15/2015
Training: New Mexico Pharmacist Prescriptive Authority for Naloxone Protocol New Mexico Pharmacists Association & Project ECHO 2014 This training fulfills the educational requirement for pharmacists in
Substance Use: Addressing Addiction and Emerging Issues
MODULE 6: SUBSTANCE USE: ADDRESSING ADDICTION AND EMERGING ISSUES Substance Use: Addressing Addiction and Emerging Issues Martha C. Romney, RN, MS, JD, MPH Assistant Professor Jefferson School of Population
Alcohol and drugs: JSNA support pack
Alcohol and drugs: JSNA support pack Key data to support planning for effective young people s specialist ROTHERHAM SUPPORTING INFORMATION This pack provides key performance information about young people
Policy on Opioid Drugs for Non-Cancer Pain and Patient Medication Agreement
Policy on Opioid Drugs for Non-Cancer Pain and Patient Medication Agreement I understand that I have apain problem that has failed to respond to other treatments. It is recommended that I begin or continue
Developing the Guernsey treatment system for substance misusers: Phases One and Two. Helen Baldwin Linda Prickett Adam Marr Jim McVeigh
Developing the Guernsey treatment system for substance misusers: Phases One and Two Helen Baldwin Linda Prickett Adam Marr Jim McVeigh Roles and responsibilities of the LJMU research team Helen Baldwin
Safer prisons: the challenge of mental ill-health and wider dual diagnosis. Sean Duggan, Chief Executive 21 March 2013
Safer prisons: the challenge of mental ill-health and wider dual diagnosis Sean Duggan, Chief Executive 21 March 2013 Dual diagnosis Dual diagnosis can mean A primary mental health problem that provokes
Drug Testing to Support Pain Management
NATIONAL REFERENCE LABORATORY Drug Testing to Support Pain Management 500 Chipeta Way, Salt Lake City, UT 84108 (800) 522-2787 (801) 583-2787 www.aruplab.com www.arupconsult.com ARUP is an enterprise of
Commissioning fact sheet for clinical commissioning groups
Commissioning fact sheet for clinical groups July 2012 This fact sheet sets out the services to be commissioned by clinical groups (CCGs) from April 2013. It also sets out the complementary services to
BOARD PAPER NHS ENGLAND
Paper 1505142 BOARD PAPER NHS ENGLAND Title: Patient and Public Voice From: Tim Kelsey, National Director for Patients and Information Purpose of paper: NHS England is committed to: promoting and upholding
BENZODIAZEPINE PRESCRIBING SUPPORT PACK
BENZODIAZEPINE PRESCRIBING SUPPORT PACK Background Prescribing of benzodiazepine drugs is widespread but dependence (both physical and psychological) and tolerance occur. This may lead to difficulty in
2012-13 Trends in Drug Treatment
Appendix: 3.4 MEETING: Clinical Commissioning Group Shadow Governing Body DATE: Thursday 22 November 2012 TITLE: Drug treatment performance report LEAD Dr Jeanelle de Gruchy, Director of Public Health
Depression in Adults
Depression in Adults A chapter of Croydon s mental health Joint Strategic Needs Assessment 2012/13 Health and Wellbeing Board 5 December 2012 Bernadette Alves, Locum Consultant in Public Health Croydon
Chapter 11 The role of healthcare professionals
Chapter 11 The role of healthcare professionals 11.1 Introduction There are three levels at which doctors are involved in responding to illicit drugs. All doctors in clinical practice will encounter patients
Engaging with the NHS reforms: A guide for local relationship support providers
Engaging with the NHS reforms: A guide for local relationship support providers The Relationships Alliance, led by Relate, Marriage Care, OnePlusOne and the Tavistock Centre for Couple Relationships, exists
Alcohol treatment in England 2012-13
Alcohol treatment in England 2012-13 October 2013 About Public Health England Public Health England s mission is to protect and improve the nation s health and to address inequalities through working with
OVERVIEW WHAT IS POLyDRUG USE? Different examples of polydrug use
Petrol, paint and other Polydrug inhalants use 237 11 Polydrug use Overview What is polydrug use? Reasons for polydrug use What are the harms of polydrug use? How to assess a person who uses several drugs
August 2011. A. Introduction
Recommendations of the Expert Group on the Regulatory Framework for products containing buprenorphine / naloxone and buprenorphine-only for the treatment of opioid dependence August 2011 A. Introduction
Utah Clinical Guidelines on Prescribing Opioids
Utah Clinical Guidelines on Prescribing Opioids Presented by: Erin Johnson, MPH January 2009 www.useonlyasdirected.org Overview Utah s prescription problem Why guidelines? Guideline process Guideline content
Alcohol and Dependence
The facts about... Alcohol and Dependence Five key things you need to know A glass of wine with dinner, a beer after work, a cocktail in the sunshine on holiday. Alcohol makes an appearance in so many
Opioids in Chronic Non Cancer Pain: The Basics
Opioids in Chronic Non Cancer Pain: The Basics List of Suggested Resources This document is a list of useful resources discovered during the development of the Opioids in Chronic Non Cancer Pain topic.
Iowa Governor s Office of Drug Control Policy
Iowa Governor s Office of Drug Control Policy medicines or take them in a manner not prescribed, we increase the risk of negative effects. It is estimated that over 35 million Americans are ages 65 and
Informatics: The future. An organisational summary
Informatics: The future An organisational summary DH INFORMATION READER BOX Policy HR/Workforce Management Planning/Performance Clinical Document Purpose Commissioner Development Provider Development Improvement
Alcohol, drugs and older people
Alcohol, drugs and older people This leaflet is for older people (defined as those aged 55 or over) who are worried about their use of alcohol, illegal drugs and/or prescribed/over-the-counter medications.
Subject: Health; food and drugs; treatment of opiate addiction. Statement of purpose: This bill proposes to require the department 6of health to
2012 Page 1 of 6 1 2 3 4 5 H.627 Introduced by Representative Pugh of South Burlington Referred to Committee on Date: Subject: Health; food and drugs; treatment of opiate addiction Statement of purpose:
The changing use of prescribed benzodiazepines and z-drugs and of over-the-counter codeine-containing products in England:
The changing use of prescribed benzodiazepines and z-drugs and of over-the-counter codeine-containing products in England: a structured review of published English and international evidence and available
Topic Area - Dual Diagnosis
Topic Area - Dual Diagnosis Dual Diagnosis is a challenging problem for both mental health and substance misuse services. People with mental health problems, who also suffer from substance misuse are at
Drugs and Alcohol in the Workplace. Guidance for Workplace Representatives
Drugs and Alcohol in the Workplace Guidance for Workplace Representatives Health and safety May 2010 Introduction The use of drugs and alcohol can be a serious workplace issue. Not only can their use lead
TESTIMONY. March 17, 2014. Rutland, VT
Community Solutions to Breaking the Cycle of Heroin & Opioid Addiction TESTIMONY Harry Chen, MD, Commissioner of Health March 17, 2014 Senate Committee on the Judiciary Franklin Conference Center at the
The National Community Detoxification Pilot
The National Community Detoxification Pilot Aoife Dermody, Progression Routes Initiative NDCI, 2011 Community Detoxification Protocols Guidelines for outpatient detoxification from methadone or benzodiazepines
Massachusetts Substance Abuse Policy and Practices. Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District
Massachusetts Substance Abuse Policy and Practices Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District November 2014 Substance Abuse and Addiction National and State opioid abuse
After seeing a patient on a Diversion Alert installment..
After seeing a patient on a Diversion Alert installment.. Recommendations from Dr. James Berry of Mercy Recovery Center OVERVIEW OF DIVERSION Manufacture Distribution Pharmacy Patient End -user OPPORTUNITIES
SPECIFICATION FOR THE LOCAL COMMISSIONED SERVICE FOR THE MANAGEMENT ALCOHOL MISUSE
SPECIFICATION FOR THE LOCAL COMMISSIONED SERVICE FOR THE MANAGEMENT OF ALCOHOL MISUSE Date: March 2015 1 1. Introduction Alcohol misuse is a major public health problem in Camden with high rates of hospital
WHAT WE KNOW. Collective Action Issue Brief #2 Updated June 2014 PRESCRIPTION PAIN MEDICATION MISUSE
Collective Action Issue Brief #2 Updated June 2014 PRESCRIPTION PAIN MEDICATION MISUSE WHAT WE KNOW The misuse and abuse of prescription drugs has become a leading cause of harm among New Hampshire adults,
National Drug Treatment Monitoring System (NDTMS) NDTMS DATA SET J
National Drug Treatment Monitoring System (NDTMS) NDTMS DATA SET J IMPLEMENTATION GUIDE FOR ADULT DRUG AND ALCOHOL TREATMENT PROVIDERS Author S Taylor Approver J Knight Date 10/7/12 Version 2.0 REVISION
Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling
Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling Patients with a substance misuse history are at increased risk of receiving inadequate
The Determinations Report: A Report On the Physician Waiver Program Established by the. Drug Addiction Treatment Act of 2000 ( DATA )
The Determinations Report: A Report On the Physician Waiver Program Established by the Drug Addiction Treatment Act of 2000 ( DATA ) Submitted by the Center for Substance Abuse Treatment, Substance Abuse
Subject: Health; food and drugs; treatment of opiate addiction. Statement of purpose: This bill proposes to require the department 6of health to
2012 Page 1 of 8 1 2 3 4 5 H.627 Introduced by Representative Pugh of South Burlington Referred to Committee on Date: Subject: Health; food and drugs; treatment of opiate addiction Statement of purpose:
Prescription drug abuse trends. Minnesota s Prescription Monitoring Program. Minnesota Rural Health Conference June 25, 2013 Duluth
Prescription drug abuse trends Minnesota s Prescription Monitoring Program Carol Falkowski Drug Abuse Dialogues www.drugabusedialogues.com Barbara Carter, Manager MN Board of Pharmacy www.pmp.pharmacy.state.mn.us
The role of addiction specialist doctors in recovery orientated treatment systems. A resource for commissioners, providers and clinicians
The role of addiction specialist doctors in recovery orientated treatment systems A resource for commissioners, providers and clinicians About Public Health England We work with national and local government,
Treatment of Chronic Pain: Our Approach
Treatment of Chronic Pain: Our Approach Today s webinar was coordinated by the National Association of Community Health Centers, a partner with the SAMHSA-HRSA Center for Integrated Health Solutions SAMHSA
Adults who misuse drugs and alcohol
West of England ESF BIG Lottery - Breaking down the barriers to employment Adults who misuse drugs and alcohol Bath and North East Somerset Baseline data Current local provision Gaps /added Prevalence
Reforms threaten government s drug strategy
Reforms threaten government s drug strategy Structural changes are being introduced in police, justice, health and local council services with too little attention to their overall impact or value for
Opioid overdose can occur when a patient misunderstands the directions
Facts About Opioid Overdose How Does an Overdose Occur? Opioid overdose can occur when a patient misunderstands the directions for use, accidentally takes an extra dose, or deliberately misuses a prescription
Brief intervention in a general hospital for problematic prescription drug use: Outcome at 3- and 12-month follow-up
Brief intervention in a general hospital for problematic prescription drug use: Outcome at 3- and 12-month follow-up Gallus Bischof, Anne Zahradnik, Christiane Otto, Brit Crackau, Ira Löhrmann, Ulrich
Executive Summary and Recommendations: National Audit of Learning Disabilities Feasibility Study
Executive Summary and Recommendations: National Audit of Learning Disabilities Feasibility Study Contents page Executive Summary 1 Rationale and potential impact of a future audit 2 Recommendations Standards
Residential rehabilitation: state of the sector in 2014 Report of a survey of providers and commissioners of residential services
Residential rehabilitation: state of the sector in 2014 Report of a survey of providers and commissioners of residential services Residential rehab: state of the sector in 2014 About Public Health England
Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas
Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas David Lakey, MD Commissioner, Department of State Health Services Lauren Lacefield Lewis Assistant Commissioner,
Dual diagnosis: a challenge for the reformed NHS and for Public Health England
Dual diagnosis: a challenge for the reformed NHS and for Public Health England A discussion paper from Centre for Mental Health, DrugScope and UK Drug Policy Commission The extent and significance of dual
Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians
Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians Although prescription pain medications are intended to improve the lives of people with pain, their increased use and misuse
PRESCRIPTION PAINKILLER OVERDOSES
IMPACT{ POLICY PRESCRIPTION PAINKILLER OVERDOSES National Center for Injury Prevention and Control Division of Unintentional Injury Prevention What s the Issue? In a period of nine months, a tiny Kentucky
BUILDING RECOVERY IN COMMUNITIES www.nta.nhs.uk
Parents with drug problems present real risks to their children. But drug treatment helps them to overcome their addiction and look after their children better PARENTS WITH DRUG PROBLEMS: HOW TREATMENT
MQAC Rules for the Management of Chronic Non-Cancer Pain
MQAC Rules for the Management of Chronic Non-Cancer Pain Effective January 2, 2012 246-919-850 Pain management Intent. These rules govern the use of opioids in the treatment of patients for chronic noncancer
These changes are prominent in individuals with severe disorders, but also occur at the mild or moderate level.
Substance-Related Disorders DSM-V Many people use words like alcoholism, drug dependence and addiction as general descriptive terms without a clear understanding of their meaning. What does it really mean
Dual Diagnosis. Dual Diagnosis Good Practice Guidance, Dept of Health (2002);
Dual Diagnosis Dual Diagnosis is a challenging problem for both mental health and substance misuse services. People with mental health problems, who also suffer from substance misuse are at an increased
Impact of Systematic Review on Health Services: The US Experience
Impact of Systematic Review on Health Services: The US Experience Walter Ling MD Integrated Substance Abuse Programs (ISAP) UCLA The effectiveness of interventions for addictions: The Drug and Alcohol
DRUG DRIVE PARTNER PACK
DRUG DRIVE PARTNER PACK AM I FIT TO DRIVE? A new drug driving law comes into force on 2 March 2015 Enter WHY IS THIS AN IMPORTANT ISSUE? The new drug driving law that comes into force on 2 March 2015 will
Michigan Guidelines for the Use of Controlled Substances for the Treatment of Pain
Michigan Guidelines for the Use of Controlled Substances for the Treatment of Pain Section I: Preamble The Michigan Boards of Medicine and Osteopathic Medicine & Surgery recognize that principles of quality
Dartmouth Medical School Curricular Content in Addiction Medicine for Medical Students (DCAMMS) Keyed to LCME Core Competency Domains ***Draft***
Dartmouth Medical School Curricular Content in Addiction Medicine for Medical Students (DCAMMS) Keyed to LCME Core Competency Domains ***Draft*** This content, sorted by LCME competencies is intended to